• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷公藤红素可减少实验性膜性肾病的蛋白尿,并可防止体外 C5b-9 诱导的足细胞损伤。

Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.

机构信息

Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.

出版信息

Kidney Int. 2010 Jun;77(11):974-88. doi: 10.1038/ki.2010.41. Epub 2010 Mar 10.

DOI:10.1038/ki.2010.41
PMID:20375980
Abstract

Membranous nephropathy is a major cause of nephrotic syndrome in adults where podocyte injuries were found to mediate the development of proteinuria. Triptolide, a major active component of Tripterygium wilfordii Hook F, has potent immunosuppressive, anti-inflammatory and antiproteinuric effects. To study its antiproteinuric properties, we established an experimental rat model of passive Heymann nephritis and a C5b-9 injury model of podocytes in vitro. Treatment or pretreatment with triptolide markedly reduced established proteinuria as well as the titer of circulating rat anti-rabbit IgG antibodies in these nephritic rats, accompanied by a reduction in glomerular C5b-9 deposits. Expression of desmin, a marker of podocyte injury, diminished after triptolide treatment, whereas quantitative analysis of mean foot process width showed that effacement of foot processes was substantially reversed. In in vitro studies we found that triptolide deactivated NADPH oxidase, suppressed reactive oxygen species generation and p38 mitogen-activated protein kinase, and restored RhoA signaling activity. Triptolide did not interfere with the formation of C5b-9 on the membrane of podocytes. Thus, triptolide reduces established heavy proteinuria and podocyte injuries in rats with passive Heymann nephritis, and protects podocytes from C5b-9-mediated injury.

摘要

膜性肾病是成人肾病综合征的主要病因,其中足细胞损伤被认为介导了蛋白尿的发生。雷公藤红素是雷公藤的主要活性成分之一,具有强大的免疫抑制、抗炎和抗蛋白尿作用。为了研究其抗蛋白尿特性,我们建立了被动性 Heymann 肾炎大鼠模型和体外 C5b-9 损伤的足细胞模型。雷公藤红素治疗或预处理明显减少了这些肾炎大鼠已建立的蛋白尿以及循环大鼠抗兔 IgG 抗体的滴度,同时减少了肾小球 C5b-9 沉积。雷公藤红素治疗后足细胞损伤标志物 desmin 的表达减少,而足突宽度的定量分析表明,足突的融合得到了很大程度的逆转。在体外研究中,我们发现雷公藤红素使 NADPH 氧化酶失活,抑制活性氧的产生和 p38 丝裂原活化蛋白激酶,并恢复 RhoA 信号活性。雷公藤红素不干扰 C5b-9 在足细胞膜上的形成。因此,雷公藤红素可减少被动性 Heymann 肾炎大鼠已建立的大量蛋白尿和足细胞损伤,并保护足细胞免受 C5b-9 介导的损伤。

相似文献

1
Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.雷公藤红素可减少实验性膜性肾病的蛋白尿,并可防止体外 C5b-9 诱导的足细胞损伤。
Kidney Int. 2010 Jun;77(11):974-88. doi: 10.1038/ki.2010.41. Epub 2010 Mar 10.
2
Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.雷公藤甲素在体内和体外均可保护足细胞免受嘌呤霉素氨基核苷诱导的损伤。
Kidney Int. 2008 Sep;74(5):596-612. doi: 10.1038/ki.2008.203. Epub 2008 May 28.
3
Triptolide attenuates proteinuria and podocyte apoptosis via inhibition of NF-κB/GADD45B.雷公藤内酯醇通过抑制 NF-κB/GADD45B 减轻蛋白尿和足细胞凋亡。
Sci Rep. 2018 Jul 18;8(1):10843. doi: 10.1038/s41598-018-29203-1.
4
Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.Rho-kinase 抑制可预防免疫复合物介导的抗足细胞肾炎的蛋白尿。
Am J Physiol Renal Physiol. 2012 Oct;303(7):F1015-25. doi: 10.1152/ajprenal.00380.2011. Epub 2012 Jul 18.
5
The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4.钙调神经磷酸酶抑制剂他克莫司可降低膜性肾病患者的蛋白尿,同时血管生成素样蛋白4水平也会下降。
PLoS One. 2014 Aug 28;9(8):e106164. doi: 10.1371/journal.pone.0106164. eCollection 2014.
6
Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway.Klotho 通过调节 TRPC6/CatL 通路稳定特发性膜性肾病足细胞的肌动蛋白细胞骨架。
Am J Nephrol. 2024;55(3):345-360. doi: 10.1159/000537732. Epub 2024 Feb 8.
7
Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.抗RAP和抗megalin抗体产生进行性被动海曼肾炎的差异能力——对特发性人类膜性肾小球肾炎发病机制的启示
J Pathol. 2006 Nov;210(3):282-7. doi: 10.1002/path.2058.
8
Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.抗糖脂抗体激活补体并促进被动型海曼肾炎中的蛋白尿。
Am J Pathol. 1994 Apr;144(4):807-19.
9
Membranous nephropathy.膜性肾病
Contrib Nephrol. 2011;169:107-125. doi: 10.1159/000313948. Epub 2011 Jan 20.
10
Triptolide ameliorates fine particulate matter-induced podocytes injury via regulating NF-κB signaling pathway.雷公藤内酯醇通过调控 NF-κB 信号通路改善细颗粒物诱导的足细胞损伤。
BMC Mol Cell Biol. 2020 Feb 3;21(1):4. doi: 10.1186/s12860-020-0248-6.

引用本文的文献

1
Early Diagnosis and Treatment of Kidney Injury: A Focus on Urine Protein.早期肾损伤的诊断与治疗:关注尿蛋白
Int J Mol Sci. 2024 Oct 17;25(20):11171. doi: 10.3390/ijms252011171.
2
Podocyte Pathogenic Bone Morphogenetic Protein-2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy.足细胞致病骨形态发生蛋白-2 途径与原发性膜性肾病中的免疫细胞行为。
Adv Sci (Weinh). 2024 Aug;11(29):e2404151. doi: 10.1002/advs.202404151. Epub 2024 May 24.
3
Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway.
Klotho 通过调节 TRPC6/CatL 通路稳定特发性膜性肾病足细胞的肌动蛋白细胞骨架。
Am J Nephrol. 2024;55(3):345-360. doi: 10.1159/000537732. Epub 2024 Feb 8.
4
The effects of Hook F on renal outcomes in type 2 diabetic kidney disease patients with severe proteinuria: a single-center cohort study.在伴有大量蛋白尿的 2 型糖尿病肾病患者中,Hook F 对肾脏结局的影响:一项单中心队列研究。
Ren Fail. 2024 Dec;46(1):2295425. doi: 10.1080/0886022X.2023.2295425. Epub 2024 Jan 4.
5
Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives.纳米技术在肾小球肾炎治疗中的应用:现状与展望。
J Nanobiotechnology. 2024 Jan 3;22(1):9. doi: 10.1186/s12951-023-02257-8.
6
Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis.雷公藤多苷治疗特发性膜性肾病的疗效与安全性:一项基于贝叶斯Meta分析的系统评价
Front Pharmacol. 2023 Aug 2;14:1183499. doi: 10.3389/fphar.2023.1183499. eCollection 2023.
7
Colquhounia root tablet in the treatment of idiopathic membranous nephropathy with subnephrotic proteinuria.考昆尼亚根片治疗特发性膜性肾病伴亚肾病性蛋白尿。
Int Urol Nephrol. 2024 Feb;56(2):699-706. doi: 10.1007/s11255-023-03682-2. Epub 2023 Jul 22.
8
Kunxian capsule alleviates podocyte injury and proteinuria by inactivating β-catenin in db/db mice.昆仙胶囊通过使db/db小鼠体内的β-连环蛋白失活来减轻足细胞损伤和蛋白尿。
Front Med (Lausanne). 2023 Jun 30;10:1213191. doi: 10.3389/fmed.2023.1213191. eCollection 2023.
9
Minnelide Markedly Reduces Proteinuria in Mice with Adriamycin Nephropathy by Protecting Against Podocyte Injury.米内利德通过防止足细胞损伤显著减少阿霉素肾病小鼠的蛋白尿。
Appl Biochem Biotechnol. 2023 Dec;195(12):7379-7396. doi: 10.1007/s12010-023-04333-z. Epub 2023 Mar 31.
10
Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature.替代医学系统在成年慢性肾脏病患者中的作用:文献系统评价
Cureus. 2022 Dec 23;14(12):e32874. doi: 10.7759/cureus.32874. eCollection 2022 Dec.